Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
The First IBCC Unveiled in Hainan 2022-12-05 15:55
Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022 2022-12-05 08:00
Telix Announces Executive Leadership Appointments 2022-12-05 06:39
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-12-03 05:10
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES $5 MILLION GIFT TO ADVANCE CLINICAL TRIALS IN RARE NEURODEVELOPMENTAL DISORDERS 2022-12-03 01:07
Sirolimus Coated Balloon in BTK Treatment makes a bold presence at VEITH 2022 - Lights up NY Times Square, NASDAQ 2022-12-02 21:10
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies 2022-12-02 18:23
CUVET Successfully Developed the First Stem Cell Transplantation Technology to Treat Pet Diabetes 2022-12-02 10:00
Innoforce Opens GMP Manufacturing Facility & Corporate Headquarters in Hangzhou, China to Provide CDMO Services for Global Supply of RNA, Cell & Gene Therapies 2022-12-02 06:00
BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine 2022-12-01 21:00
MGI Cements Its Presence and Contribution in Singapore's Genomics Landscape at ESMO Asia Congress 2022 2022-12-01 17:10
SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO 2022-12-01 09:30
NCH ASIA PACIFIC PUTS BACK THE FUN IN CSR ACTIVITIES WITH NCH PLOGGO 2022-12-01 09:00
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio 2022-12-01 08:00
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index 2022-11-30 22:15
TIANGEN to Roll out a Stunning Automated Solution at Cell Bio 2022 2022-11-30 21:20
Ascletis Announces Completion of 180 Patient Enrollment for Phase II Clinical Trial of FASN Inhibitor ASC40 for Acne 2022-11-30 20:39
WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan 2022-11-30 08:00
First Patient dosed in a Head-to-Head First-Line Bridging Study of HANSIZHUANG for ES-SCLC treatment in the US 2022-11-30 08:00
TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife® Satylia® in Germany 2022-11-29 18:15
1 98 99 100 101 102 412